文献速递生殖医学

临床医生面对嵌合体的困境——来自内细胞团活检的启示

The clinicians´ dilemma with mosaicism-an insight from inner cell mass biopsies.
PubMed 文献 · Hum Reprod · 2019-01-01

该观察性描述研究在私立不孕症中心于2016年8月至2017年1月进行,比较卵裂期、滋养外胚层和内细胞团活检的一致性。84枚胚胎中50枚(59.5%)三次结果完全一致,34枚(40.4%)至少两次结果不一致,9枚(10.7%)三次结果完全不吻合。滋养外胚层与内细胞团活检一致性几乎完美,但卵裂期与内细胞团活检一致性仅为中等。

要点

  • 滋养外胚层与内细胞团活检一致性几乎完美(Kappa=0.857),卵裂期与内细胞团仅为中等(Kappa=0.553)。
  • 84枚胚胎中50枚(59.5%)三次活检结果完全一致,34枚(40.4%)至少两次结果不一致。
  • 三种活检方法间明显不一致凸显PGT-A遗传检测的局限性。

核心结论

  • 滋养外胚层活检与内细胞团活检的可靠性几乎完美,但卵裂期活检与内细胞团活检的可靠性仅为中等。

研究设计与样本

  • 该研究为观察性描述研究,在私立不孕症中心于2016年8月至2017年1月进行。
  • 女性平均年龄33.9岁(范围24至46岁),每对夫妇平均活检胚胎数2.2枚(范围1至7枚)。
  • 因遗传检测周转时间和当地ART法律禁止胚胎冷冻,在D3卵裂期进行卵裂球活检。
  • 对未选择移植的剩余囊胚,在D5额外进行滋养外胚层活检和内细胞团活检,仅纳入未选择移植且依法未冷冻的剩余囊胚。

主要发现

  • 84枚胚胎中50枚(59.5%)三次活检结果完全一致,34枚(40.4%)至少两次结果不一致,9枚(10.7%)三次结果完全不吻合。
  • D3与BLASTO-TE、D3与BLASTO-ICM、BLASTO-TE与BLASTO-ICM之间的假阳性率分别为26.4%、30.2%和7.5%。
  • D3与BLASTO-TE、D3与BLASTO-ICM、BLASTO-TE与BLASTO-ICM的Kappa一致性分别为0.647、0.553和0.857。
  • D3与BLASTO-TE、D3与BLASTO-ICM、BLASTO-TE与BLASTO-ICM的可靠性分别可解释为中等、中等和几乎完美。

临床怎么用

  • 作者认为,三种PGT-A方法之间的明显不一致凸显了遗传检测的局限性,并强调需要持续研究以提高PGT-A结果的准确性。
  • 作者指出,在当前证据质疑遗传结果可靠性的情况下,生殖专家将继续面临移植还是丢弃胚胎的艰难决策。

局限性

  • 本研究的局限性在于,选择移植的胚胎未在D5进行活检,可能导致一致/不一致率存在偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: How reliable are cleavage stage and trophectoderm (TE) biopsies compared to inner cell mass (ICM) biopsies? SUMMARY ANSWER: The reliability of TE biopsy compared to ICM biopsy is almost perfect, but only substantial between cleavage stage biopsy and ICM biopsy. WHAT IS KNOWN ALREADY: One of the prevailing reasons for implantation failure is presumed to be chromosomal aneuploidy in human preimplantation embryos. Preimplantation genetic testing for aneuploidies (PGT-A) has been introduced into assisted reproduction in an effort to increase pregnancy rates. Increasing evidence indicates that genetic results obtained following blastomere or TEbiopsy may not accurately reflect the true genetic status of the embryo due to the presence of embryonic mosaicism, and therefore the reliability of PGT is highly controversial. STUDY DESIGN, SIZE, DURATION: This was an observational descriptive study, performed in a private infertility centre from August 2016 to January 2017. PARTICIPANTS/MATERIALS, SETTING, METHODS: The mean female age was 33.9 years, ranging from 24 to 46 years, and the mean number of biopsied embryos per couple was 2.2 (range 1-7 embryos). Blastomere biopsies had been performed at cleavage stage on Day 3 (D3) due to the turnover time of genetic testing and the inability to cryopreserve embryos in accordance with the local law governing ART. To confirm the genetic results in embryos not chosen for transfer, additional biopsies of the TE at blastocyst stage (BLASTO-TE) as well as of the ICM (BLASTO-ICM) were performed on D5. Only surplus blastocysts, which had not been selected for transfer and were not cryopreserved in accordance with the law governing ART, had been included. MAIN RESULTS AND THE ROLE OF CHANCE: Comparison of all biopsies (D3/BLASTO-ICM/BLASTO-TE) per embryo demonstrated that 50 (59.5%) out of 84 embryos showed concordance in all three results (= full concordance). Thirty-four (40.4%) embryos had at least two discordant results between the three biopsies, regardless of whether the embryo diagnosis (aneuploid/euploid) was discordant or not, or in aneuploid embryos, whether the chromosomal patterns were inconsistent. Nine (= 10.7%) embryos had complete discordance between all three biopsies. False positive results between D3/BLASTO-TE, D3/BLASTO-ICM and BLASTO-TE/BLASTO-ICM were 26.4%/30.2% and 7.5%, respectively, while the Kappa agreement between the different approaches was 0.647, 0.553 and 0.857, respectively. Therefore the reliability of D3/BLASTO-TE, D3/BLASTO-ICM and BLASTO-TE/BLASTO-ICM can be interpreted as substantial, as moderate and as almost perfect. LIMITATIONS, REASONS FOR CAUTION: The limitation of this study is the possible bias in the concordance/discordance rate because embryos that had been selected for transfer did not undergo biopsy on D5. WIDER IMPLICATIONS OF THE FINDINGS: The obvious discordance between the three different approaches for PGT-A underlines the limitations of genetic testing and highlights the importance of ongoing research in order to improve the accuracy of PGT-A results. Until then reproductive specialists will continue to make challenging decisions on whether to transfer or discard an embryo in light of current evidence questioning the reliability of genetic results. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by Igenomix. The funder provided support in the form of salary for R.C. The co-author R.C. is an employee of Igenomix. She participated in the blinded analysis of the samples; however the final data collection and statistical analysis of the results, as well as the decision to publish, was taken by B.L, I.E. and H.F. The authors B.L., I.E., A.L., A.B., A.A., N.D. and H.F. have no competing interests. The funder did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The commercial affiliation of R.C. did not play any role in the study. TRIAL REGISTRATION NUMBER: This study was approved by the Ethics Committee of IVIRMA Middle East Fertility Clinic, Abu Dhabi, UAE (Research Ethics Committee IVI-MEREFA009a/2017).

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Lawrenz B, El Khatib I, Liñán A, et al. The clinicians´ dilemma with mosaicism-an insight from inner cell mass biopsies. Hum Reprod. 2019. PMID: 31114858. doi:10.1093/humrep/dez055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。